The global bioprosthetics market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The growth of this market is attributed to the increasing demand for bioprosthetic products in various applications such as cardiovascular, plastic surgery and wound healing. The allograft segment is expected to dominate the global bioprosthetics market during the forecast period due to its high demand in cardiovascular applications.
Some Of The Growth Factors Of This Market:
- The global population is increasing and aging, which will lead to an increase in demand for prosthetic devices.
- Advances in technology are leading to more sophisticated prosthetic devices that are more affordable and easier to use, which will lead to increased demand for these devices.
- The need for improved access to healthcare in developing countries is leading many people who would not have been able to afford a prosthetic device before now being able to do so, which will lead to increased demand for these devices as well as the materials needed for them such as bioprosthetics.
- There is a growing awareness of the importance of physical activity and exercise among people with disabilities, which has led many people with disabilities who would not have been active before now being active and exercising regularly, which has led some of them towards using prosthetic devices such as running blades or handcycles that require bioprosthetics materials such as carbon fiber or titanium alloys; this trend will also likely continue into the future due to its popularity among disabled athletes.
- As populations age around the world there is an increasing need for medical care services including rehabilitation services; this trend will also likely continue into the future due to its popularity among elderly populations.
Industry Growth Insights published a new data on “Bioprosthetics Market”. The research report is titled “Bioprosthetics Market research by Types (Allograft, Xenograft), By Applications (Cardiovascular, Plastic Surgery & Wound Healing, Others), By Players/Companies LeMaitre Vascular, Braile Biomedica, Labcor Laboratorios Ltd., Maquet Metinge Group, Medtronic Plc., Aortech International Plc, CryoLife, Sorin Group, Humacyte, Ethicon, LifeCell International, Organogenesis, St. Jude Medical, Edwards Lifesciences Corporation, JenaValve Technology GmbH”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Bioprosthetics Market Research Report
By Type
Allograft, Xenograft
By Application
Cardiovascular, Plastic Surgery & Wound Healing, Others
By Companies
LeMaitre Vascular, Braile Biomedica, Labcor Laboratorios Ltd., Maquet Metinge Group, Medtronic Plc., Aortech International Plc, CryoLife, Sorin Group, Humacyte, Ethicon, LifeCell International, Organogenesis, St. Jude Medical, Edwards Lifesciences Corporation, JenaValve Technology GmbH
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Bioprosthetics Market Report Segments:
The global Bioprosthetics market is segmented on the basis of:
Types
Allograft, Xenograft
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular, Plastic Surgery & Wound Healing, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- LeMaitre Vascular
- Braile Biomedica
- Labcor Laboratorios Ltd.
- Maquet Metinge Group
- Medtronic Plc.
- Aortech International Plc
- CryoLife
- Sorin Group
- Humacyte
- Ethicon
- LifeCell International
- Organogenesis
- St. Jude Medical
- Edwards Lifesciences Corporation
- JenaValve Technology GmbH
Highlights of The Bioprosthetics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Allograft
- Xenograft
- By Application:
- Cardiovascular
- Plastic Surgery & Wound Healing
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Bioprosthetics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Bioprosthetics is a term used to describe medical devices that use biotechnology to create replacement body parts. These devices can be used for a variety of purposes, including replacing lost limbs, repairing damage to the skin and tissue, and providing support for people with disabilities.
Some of the major companies in the bioprosthetics market are LeMaitre Vascular, Braile Biomedica, Labcor Laboratorios Ltd., Maquet Metinge Group, Medtronic Plc., Aortech International Plc, CryoLife, Sorin Group, Humacyte, Ethicon, LifeCell International, Organogenesis, St. Jude Medical, Edwards Lifesciences Corporation, JenaValve Technology GmbH.
The bioprosthetics market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Bioprosthetics Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Bioprosthetics Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Bioprosthetics Market - Supply Chain
4.5. Global Bioprosthetics Market Forecast
4.5.1. Bioprosthetics Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Bioprosthetics Market Size (000 Units) and Y-o-Y Growth
4.5.3. Bioprosthetics Market Absolute $ Opportunity
5. Global Bioprosthetics Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Bioprosthetics Market Size and Volume Forecast by Type
5.3.1. Allograft
5.3.2. Xenograft
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Bioprosthetics Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Bioprosthetics Market Size and Volume Forecast by Application
6.3.1. Cardiovascular
6.3.2. Plastic Surgery & Wound Healing
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Bioprosthetics Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Bioprosthetics Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Bioprosthetics Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Bioprosthetics Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Bioprosthetics Demand Share Forecast, 2019-2029
9. North America Bioprosthetics Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Bioprosthetics Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Bioprosthetics Market Size and Volume Forecast by Application
9.4.1. Cardiovascular
9.4.2. Plastic Surgery & Wound Healing
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Bioprosthetics Market Size and Volume Forecast by Type
9.7.1. Allograft
9.7.2. Xenograft
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Bioprosthetics Demand Share Forecast, 2019-2029
10. Latin America Bioprosthetics Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Bioprosthetics Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Bioprosthetics Market Size and Volume Forecast by Application
10.4.1. Cardiovascular
10.4.2. Plastic Surgery & Wound Healing
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Bioprosthetics Market Size and Volume Forecast by Type
10.7.1. Allograft
10.7.2. Xenograft
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Bioprosthetics Demand Share Forecast, 2019-2029
11. Europe Bioprosthetics Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Bioprosthetics Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Bioprosthetics Market Size and Volume Forecast by Application
11.4.1. Cardiovascular
11.4.2. Plastic Surgery & Wound Healing
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Bioprosthetics Market Size and Volume Forecast by Type
11.7.1. Allograft
11.7.2. Xenograft
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Bioprosthetics Demand Share, 2019-2029
12. Asia Pacific Bioprosthetics Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Bioprosthetics Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Bioprosthetics Market Size and Volume Forecast by Application
12.4.1. Cardiovascular
12.4.2. Plastic Surgery & Wound Healing
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Bioprosthetics Market Size and Volume Forecast by Type
12.7.1. Allograft
12.7.2. Xenograft
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Bioprosthetics Demand Share, 2019-2029
13. Middle East & Africa Bioprosthetics Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Bioprosthetics Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Bioprosthetics Market Size and Volume Forecast by Application
13.4.1. Cardiovascular
13.4.2. Plastic Surgery & Wound Healing
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Bioprosthetics Market Size and Volume Forecast by Type
13.7.1. Allograft
13.7.2. Xenograft
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Bioprosthetics Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Bioprosthetics Market: Market Share Analysis
14.2. Bioprosthetics Distributors and Customers
14.3. Bioprosthetics Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. LeMaitre Vascular
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Braile Biomedica
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Labcor Laboratorios Ltd.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Maquet Metinge Group
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Medtronic Plc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Aortech International Plc
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. CryoLife
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Sorin Group
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Humacyte
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Ethicon
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. LifeCell International
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Organogenesis
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. St. Jude Medical
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Edwards Lifesciences Corporation
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. JenaValve Technology GmbH
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook